2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome

Jack Wei Chieh Tan, Derek P. Chew, David Brieger, John Eikelboom, Gilles Montalescot, Junya Ako, Byeong Keuk Kim, David K.L. Quek, Sarah J. Aitken, Clara K. Chow, Sok Chour, Hung Fat Tse, Upendra Kaul, Isman Firdaus, Takashi Kubo, Boon Wah Liew, Tze Tec Chong, Kenny Y.K. Sin, Hung I. Yeh, Wacin BuddhariNarathip Chunhamaneewat, Faisal Hasan, Keith A.A. Fox, Quang Ngoc Nguyen, Sidney T.H. Lo

Research output: Contribution to journalArticlepeer-review

Abstract

The unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be routinely applied to these populations. The Asian Pacific Society of Cardiology developed these consensus recommendations to summarise current evidence on the management of CCS and provide recommendations to assist clinicians treat patients from the region. The consensus recommendations were developed by an expert consensus panel who reviewed and appraised the available literature, with focus on data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting recommendations provide guidance on the assessment and management of bleeding and ischaemic risks in Asian CCS patients. Furthermore, the selection of long-term antithrombotic therapy is discussed, including the role of single antiplatelet therapy, dual antiplatelet therapy and dual pathway inhibition therapy.

Original languageEnglish
Article numbere26
JournalEuropean Cardiology Review
Volume16
DOIs
Publication statusPublished - 2021

Keywords

  • Anticoagulant
  • Antiplatelet
  • Asia-Pacific
  • Bleeding
  • Chronic coronary syndrome
  • Consensus
  • Ischaemia

Fingerprint

Dive into the research topics of '2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome'. Together they form a unique fingerprint.

Cite this